Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Characterizing opioid use in a US population with migraine: Results from the CaMEO study.

< BACK TO ARCHIVE


Papers: 13 Jun 2020 - 19 Jun 2020


Human Studies

PAIN TYPE:
Migraine/Headache


2020 Jun 11


Neurology


http://www.ncbi.nlm.nih.gov/pubmed/32527971?dopt=Abstract

Characterizing opioid use in a US population with migraine: Results from the CaMEO study.

Authors

Characterizing opioid use in a US population with migraine: Results from the CaMEO study.
Lipton RB, Buse DC, Friedman BW, Feder L, Adams A M, Fanning KM, Reed ML, Schwedt TJ
Neurology. 2020 Jun 11.
PMID: 32527971.

Abstract

To determine the prevalence of and risk factors associated with opioid use in the treatment of migraine, we examined demographics and clinical characteristics of 867 individuals who reported using opioids for the treatment of migraine.
Read This Paper